Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous Ganaxolone in Status Epilepticus
Conditions
Interventions
Ganaxolone
Placebo
Locations
74
United States
Marinus Research Site
Birmingham, Alabama, United States
Marinus Research Site
Phoenix, Arizona, United States
Marinus Research Site
Little Rock, Arkansas, United States
Marinus Research Site
Downey, California, United States
Marinus Research Site
La Jolla, California, United States
Marinus Research Site
Orange, California, United States
Start Date
December 9, 2020
Primary Completion Date
March 30, 2024
Completion Date
April 28, 2024
Last Updated
May 29, 2025
NCT05140265
NCT06100978
NCT06590883
NCT06564662
NCT06344338
NCT07383779
Lead Sponsor
Marinus Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions